SEMAGLUTIDE
GLP-1 receptor agonist
May help reduce appetite
Supports blood-sugar regulation
May support gradual weight reduction
Typically the more cost-conscious option
Choose one to see options and pricing.
Provider-Prescribed GLP-1 Therapy
Complete a brief health assessment for review by a licensed healthcare provider. If appropriate, your personalized treatment plan will be prescribed and delivered directly to your door.
Choose a monthly program for $167 per month or save with the 3-month program for $467 total, which is approximately $155.67 per month. Treatment is available only following evaluation and approval by a licensed healthcare provider.
Prescription treatment requires evaluation and approval by a licensed healthcare provider. Eligibility is not guaranteed. Individual treatment plans and outcomes vary. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality before marketing.
Which option may be right for you?
GLP-1 receptor agonist
May help reduce appetite
Supports blood-sugar regulation
May support gradual weight reduction
Typically the more cost-conscious option
GLP-1 + GIP receptor agonist
May help reduce appetite and food cravings
Supports blood-sugar regulation
Acts on two hormone pathways
Individual results and side effects vary
Provider-guided care, delivered to your door
GET STARTED →Prescription required. A licensed provider determines whether treatment is medically appropriate. Completing an assessment does not guarantee a prescription. Individual results vary.
If prescribed, treatment may include a compounded medication. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing. VevaRx is not a pharmacy. Medication is dispensed by a licensed pharmacy when prescribed.
Answer a few quick questions to discover which provider-guided plan may fit your goals.
By submitting, you agree to receive wellness updates from VevaRX. We respect your privacy and will never share your information.